Group One Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,693
Closed -$106K 7950
2025
Q1
$106K Buy
+21,693
New +$130K ﹤0.01% 4555
2024
Q4
Sell
-9,431
Closed -$82.4K 7282
2024
Q3
$98K Sell
9,431
-6,652
-41% -$111K ﹤0.01% 4197
2024
Q2
$317K Sell
16,083
-10,050
-38% -$201K ﹤0.01% 2986
2024
Q1
$669K Sell
26,133
-21,272
-45% -$545K ﹤0.01% 2461
2023
Q4
$1.31M Buy
47,405
+14,169
+43% +$864K ﹤0.01% 2216
2023
Q3
$2.02M Sell
33,236
-6,562
-16% -$461K 0.01% 1635
2023
Q2
$2.62M Buy
39,798
+31,752
+395% +$2.32M 0.01% 1458
2023
Q1
$512K Buy
+8,046
New +$919K ﹤0.01% 2762
2022
Q4
Sell
-7,875
Closed -$1.11M 7251
2022
Q3
$997K Buy
7,875
+4,948
+169% +$560K ﹤0.01% 2591
2022
Q2
$242K Buy
2,927
+1,211
+71% +$93.9K ﹤0.01% 4119
2022
Q1
$166K Sell
1,716
-6,040
-78% -$797K ﹤0.01% 4992
2021
Q4
$1.55M Sell
7,756
-5,080
-40% -$1.2M ﹤0.01% 2873
2021
Q3
$3.18M Buy
12,836
+836
+7% +$239K ﹤0.01% 2178
2021
Q2
$4.97M Sell
12,000
-2,417
-17% -$958K 0.01% 1694
2021
Q1
$5.63M Buy
14,417
+8,198
+132% +$4.04M 0.01% 1414
2020
Q4
$3.49M Buy
6,219
+4,561
+275% +$2.89M 0.01% 1579
2020
Q3
$1.16M Sell
1,658
-629
-28% -$491K ﹤0.01% 2062
2020
Q2
$1.81M Sell
2,287
-3,200
-58% -$2.41M 0.01% 1534
2020
Q1
$3.27M Buy
5,487
+3,857
+237% +$3.76M 0.03% 745
2019
Q4
$1.85M Sell
1,630
-111
-6% -$121K 0.01% 1337
2019
Q3
$2.07M Sell
1,741
-831
-32% -$1.27M 0.02% 1194
2019
Q2
$4.24M Buy
2,572
+2,179
+554% +$3.77M 0.04% 619
2019
Q1
$800K Sell
393
-2,102
-84% -$3.7M 0.01% 1566
2018
Q4
$3.21M Sell
2,495
-1,355
-35% -$2.08M 0.03% 736
2018
Q3
$7.28M Sell
3,850
-391
-9% -$808K 0.06% 396
2018
Q2
$8.62M Buy
4,241
+1,529
+56% +$3.49M 0.07% 302
2018
Q1
$6M Buy
+2,712
New +$6.9M 0.06% 385
2017
Q2
Sell
-670
Closed -$808K 4746
2017
Q1
$789K Buy
670
+57
+9% +$58.1K 0.01% 1503
2016
Q4
$490K Sell
613
-595
-49% -$472K ﹤0.01% 1787
2016
Q3
$1.06M Sell
1,208
-853
-41% -$618K 0.01% 1242
2016
Q2
$1.16M Sell
2,061
-1,964
-49% -$1.11M 0.01% 1167
2016
Q1
$2.22M Buy
4,025
+918
+30% +$564K 0.03% 710
2015
Q4
$2.58M Buy
3,107
+1,499
+93% +$1.5M 0.03% 704
2015
Q3
$1.78M Buy
1,608
+1,535
+2,103% +$2.8M 0.02% 863
2015
Q2
$159K Sell
73
-455
-86% -$927K ﹤0.01% 2714
2015
Q1
$827K Sell
528
-498
-49% -$657K 0.01% 1230
2014
Q4
$1.22M Buy
1,026
+908
+769% +$607K 0.02% 950
2014
Q3
$55K Buy
+118
New +$54.4K ﹤0.01% 3450
2014
Q2
Sell
-173
Closed -$55.5K 5167
2014
Q1
$51K Buy
+173
New +$52.4K ﹤0.01% 3609

Other funds holding BLUE

Group One Trading's BLUE Position: Q2 2025 in Review

Group One Trading sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 21,693 shares — an estimated $106K sold.

Group One Trading first reported a position in BLUE in Q1 2014 and held it in 39 quarters. The position peaked at $8.62M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Group One Trading reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 21,693 bluebird bio shares in Q2 2025, an estimated $106K.
  • Group One Trading first reported a position in bluebird bio in Q1 2014 and held it in 39 quarters.
  • Group One Trading's bluebird bio position peaked at $8.62M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.